大型药企转向中国寻药以应对专利悬崖的数十亿美元交易潮

大型药企转向中国寻药以应对专利悬崖的数十亿美元交易潮

Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals

Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" d…